Filter
179
Text search:
DTG
Featured
Recommendations
12
New Publications
41
Language
Document type
No document type
113
Guidelines
31
Studies & Reports
21
Manuals
4
Fact sheets
3
Infographics
2
Strategic & Response Plan
2
Training Material
1
Brochures
1
Situation Updates
1
Countries / Regions
Zambia
6
Kenya
6
Malawi
6
South Africa
5
Namibia
4
Russia
4
Congo, Democratic Republic of
3
Germany
3
Mozambique
3
Botswana
3
Myanmar / Burma
3
Global
3
Nigeria
2
Ethiopia
2
Zimbabwe
2
Philippines
2
Argentina
2
Brazil
2
Ukraine
2
Lesotho
2
Western and Central Europe
2
Africa
2
Guinea
1
Sierra Leone
1
Liberia
1
Senegal
1
Ghana
1
Uganda
1
Haiti
1
India
1
Nepal
1
South Sudan
1
Syria
1
Cambodia
1
Rwanda
1
Indonesia
1
Bangladesh
1
Central African Republic
1
Eswatini/ Swaziland
1
Yemen
1
Middle East and North Africa
1
South–East Asia Region
1
Western Pacific Region
1
Paraguay
1
Asia
1
Venezuela
1
Eastern Europe
1
Albania
1
Armenia
1
Tajikistan
1
Moldova
1
Authors & Publishers
Publication Years
Category
Countries
66
Clinical Guidelines
21
Public Health
3
Women & Child Health
3
Key Resources
2
Pharmacy & Technologies
2
Annual Report MEDBOX
1
General Guidelines
1
Toolboxes
HIV
88
Zika
9
TB
7
Refugee
6
Conflict
3
Ebola
2
Rapid Response
2
Pharmacy
2
Mental Health
1
AMR
1
COVID-19
1
NTDs
1
Technical Update
HIV Treatment
July 2017
HIV i-Base
July 2018
WHO’s antiretroviral treatment (ART) clinic-based acquired drug resistance survey method yields robust estimates of HIV viral suppression and acquired HIV drug resistance in adults, children and adolescents taking both dolutegravir and non-dolutegravir based regimens.
Results are used to inform A
...
Médecins sans Frontières access campaign
Issue Brief
Accessed: 28.11.2019
Avec l’essor des traitements antirétroviraux (TAR) à base de dolutégravir (DTG) pour soigner les personnes vivant avec
le VIH dans le monde, il est important d’estimer la vitesse à laquelle la résistance acquise au
...
July 2019
Policy brief
HIV Treatment
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi
...
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0164619 October 13, 2016
Review
www.co-hivandaids.com
Volume 12 Number 4 July 2017
aktualisiert am 14.03.2016
Октябрь 2017
Русский
Рекомендации EACS 9.0
Em meados de 2021, os programas nacionais de SIDA começaram a fazer a transição do tratamento para crianças que vivem com VIH dolutegravir (DTG) 10 mg sulcado, comprimidos dispersíveis, também conhecido como
...
The HIV drug resistance report 2021 summarizes findings from 38 countries that had finalized the surveys by the time of this report and shared data with WHO.
Pretreatment HIVDR to non-nucleoside reverse-transcriptase inhibitors (NNRTI) can affect more than 10% of adults starting therapy and is fo
...
HIV Treatment
Policy Brief
July 2017
